CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
for
Breast Carcinoma
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 0+
Code: NCT06915168
Recruiting
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors
for
Estrogen Receptor-Positive Breast Carcinoma
Location: Ely MN, Duluth MN, Virginia MN, Rochester MN,
Sponsor: Mayo Clinic
Sex: Female
Age: 18+
Code: NCT06028022
Phase2, Recruiting
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
for
Breast Carcinoma
Location: Boston MA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT02610426
Recruiting
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
for
Breast Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT05056857
Recruiting
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
for
Breast Carcinoma, Breast Neoplasm
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04799535
Recruiting
Interested in new breast cancer trials?
Get alerts for new trials in your area by subscribing now
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
for
Breast Carcinoma, Neuropathy
Location: Boston MA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT02610439
Recruiting
Cancer Genetic Testing in Ethnic Populations
for
Breast Carcinoma, Carcinoma of Unknown Primary,
Location: Jacksonville FL, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04475640
Recruiting
The Ohio State University (OSU) SCREEN Community Program
for
Breast Carcinoma, Cervical Carcinoma, Colorectal Carcinoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 0+
Code: NCT06666192
Recruiting
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
for
Breast Carcinoma, Metastatic Breast Carcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06217874
Recruiting
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
for
Breast Carcinoma, Esophageal Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT00991094
Recruiting
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Location: Boston MA, New York NY, Philadelphia PA, Durham NC,
Sponsor: University Medical Center Nijmegen
Sex: Female
Age: 25 - 50
Code: NCT04294927
Recruiting
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
for
Mesothelioma, Malignant Mesothelioma (MM),
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05960773
Phase2, Recruiting
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
for
Breast Carcinoma, Colorectal Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06130826
Phase1, Recruiting
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05111561
Phase1, Recruiting
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
for
Vaginal Atrophy, Breast Carcinoma
Location: Ann Arbor MI
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Female
Age: 22+
Code: NCT05379153
Phase3, Recruiting
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer